John Hernandez sold $739k of RMD
director at RESMED INC. 2,575 shares at an average of $287.10, traded Aug 18, 2025, filed Aug 19, 2025.
Score components
- +15RoleDirector
- +21Trade size$739k at market
- +10Share of holdings soldSold 39% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-020653, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 18, 2025 | MOption exercise ResMed Common Stock | +2,575 | $148.90 | $383k | 6,620 | Aug 19, 2025 |
| Aug 18, 2025 | SOpen-market sale ResMed Common Stock | -2,575 | $287.10 | $739k | 4,045 | Aug 19, 2025 |
| Aug 18, 2025 | MOption exercise ResMed Common Stock Optionsderivative | -2,575 | $0.00 | $0 | 0 | Aug 19, 2025 |
Related signals
Other insiders at RESMED INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.1M 4,991 shares | -1% | |
| 23Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.1M 4,991 shares | -1% | |
| 16Weak | RESMED INC | Peter C Farrell director | $228k 970 shares | -2% | |
| 30Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.3M 4,991 shares | -1% | |
| 28Weak | RESMED INC | Peter C Farrell director | $503k 2,000 shares | -3% | |
| 30Weak | RESMED INC | Brett Sandercock Chief Financial Officer | $244k 1,000 shares | -1% | |
| 10Weak | RESMED INC | Michael J Rider Global General Counsel | $12k 50 shares | -1% | |
| 38Weak | RESMED INC | Jan De Witte director | $524k 2,055 shares | -33% | |
| 20Weak | RESMED INC | Jan De Witte director | $122k 487 shares | -8% | |
| 28Weak | RESMED INC | Peter C Farrell director | $504k 2,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.